A CRISPR Gene Editing Update

Glenn Yiu, MD, PhD

Show Description +

Glenn Yiu, MD, PhD, takes a look at advances in gene editing in the EDIT-101 program for patients with type 10 Leber congenital amaurosis and work within his own lab for patients with wet AMD.

Posted: 11/29/2023

Keywords:

retina-meeting-recap

•

CRISPR

•

gene editing

•

Leber congenital amaurosis

•

Wet AMD

•

Retina Subspecialty Day

Up Next

Name: A CRISPR Gene Editing Update
Uploaded: 2023-11-29T22:41:58+00:00
Description: Glenn Yiu, MD, PhD, takes a look at advances in gene editing in the EDIT-101 program for patients with type 10 Leber congenital amaurosis and work within his own lab for patients with wet AMD.

A New Approach to Combatting Blindness in RP

Russell N. Van Gelder, MD, PhD

Tackling TRDs with Limited Membranectomy

John W. Kitchens, MD

Working Toward Diversity in Retina Clinical Trials

Adrienne W. Scott, MD

Diversity in Ocular Oncology

Basil K. Williams Jr, MD

The Latest in Retina Surgical Instrumentation

David R. Chow, MD

Update on Glaucoma Lasers

Aaki Shukla, MD, and Mary Qiu, MD

Impact of 6-Week Treatment With Lotilaner Ophthalmic Solution, 0.25% on Eyes With Severe Demodex Blepharitis

Mitchell Shultz, MD

Walking Over a Flat Earth: A Jump Toward Diversity, Equity, and Inclusion (DEI)

Basil Williams, MD

$Rethinking Refractive Surgery: What’s New In 2023?$

Rethinking Refractive Surgery: What’s New In 2023?

George O. Waring IV, MD, FACS

Intracameral Low Molecular Weight Heparin for DMEK: A Pilot Safety Study

Rahul Tonk, MD, MBA

Combination Therapy in the Treatment of Dry Eye vs. Traditional Cyclosporine

John A. Hovanesian, MD

Wet AMD Gene Therapy at 3 Years: Ixo-vec

Carl D. Regillo, MD, FACS

Pegcetacoplan Extension Study Update

Jeffrey S. Heier, MD

Two Years of Treatment with Avacincaptad Pegol

Arshad M. Khanani, MD, MA

Efficacy of Faricimab with PEDs Revealed

Jennifer I. Lim, MD

Genetics: Now or Later

Inas Aboobakar, MD

New Glaucoma Devices in the Pipeline

Matt Schlenker, MD

Virtual Visual Fields: Are They Ready for Prime Time?

Steven R. Sarkisian Jr, MD

Cutting-Edge Translational Research From the Next Generation

Jodhbir Singh Mehta, MD, PhD

Visual Outcomes With a Small-Aperture IOL in Post-Radial Keratotomy Patients

Sudhinder Koushik, MD

Drug-Eluting IOLs

Kenneth Mandell, MD, PhD

Pearls for Subretinal Gene Therapy

Christina Y. Weng, MD, MBA

Back to All Videos

A CRISPR Gene Editing Update

Glenn Yiu, MD, PhD

Glenn Yiu, MD, PhD, takes a look at advances in gene editing in the EDIT-101 program for patients with type 10 Leber congenital amaurosis and work within his own lab for patients with wet AMD.

Posted: 11/29/2023

Keywords:

retina-meeting-recap

•

CRISPR

•

gene editing

•

Leber congenital amaurosis

•

Wet AMD

•

Retina Subspecialty Day

Please log in to leave a comment.

Meeting Coverage:

American Academy of Ophthalmology

A CRISPR Gene Editing Update

Up Next

A CRISPR Gene Editing Update

More From AAO: 2023 Coverage